REPROCELL joins consortium to develop COV-2 mRNA vaccine
REPROCELL is joining a consortium with North American and European partners to develop a novel mRNA vaccine against CoV-2. REPROCELL and the other partners have extensive experience in the mRNA vaccine field which will